Kirby Reiterated at Buy and 3 Reiterated Ratings to Recognize

Wall St. Watchdog reveals information about companies for which stock analysts reiterated their ratings on November 29th.

Biogen Idec (NASDAQ:BIIB): Argus reiterated its rating of Buy for this company and changed its price target from $155 to $160.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

PulteGroup (NYSE:PHM): Compass Point reiterated its rating of Buy for this company and changed its price target from $19 to $21.

Kirby (NYSE:KEX): Wunderlich reiterated its rating of Buy for this company and changed its price target from $63 to $65.

ANN (NYSE:ANN): FBR Capital reiterated its rating of Outperform for this company and changed its price target from $35 to $39.

Don’t Miss: Startup Whiz Kids are Using These Tricks to Battle Bigger Companies.